Journal article
Eligibility criteria from pharmaceutical randomised controlled trials of idiopathic pulmonary fibrosis: a registry-based study
Abstract
BACKGROUND: Little is known about generalisability of randomised controlled trials (RCTs) for idiopathic pulmonary fibrosis (IPF). We evaluated eligibility criteria for phase III IPF RCTs to determine their representativeness in clinical registries, and calculated forced vital capacity (FVC) changes according to eligibility criteria.
METHODS: Common eligibility criteria used in >60% of IPF RCTs were identified from a literature search and …
Authors
Khor YH; Schulte M; Johannson KA; Marcoux V; Fisher JH; Assayag D; Manganas H; Khalil N; Kolb M; Ryerson CJ
Journal
European Respiratory Journal, Vol. 61, No. 5,
Publisher
European Respiratory Society (ERS)
Publication Date
5 2023
DOI
10.1183/13993003.02163-2022
ISSN
0903-1936